Cargando…
α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation
Aggregation of the protein α-Synuclein (αSyn) is of great interest due to its involvement in the pathology of Parkinson’s disease. However, under in vitro conditions αSyn is very soluble and kinetically stable for extended time periods. As a result, most αSyn aggregation assays rely on conditions th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ireland Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451039/ https://www.ncbi.nlm.nih.gov/pubmed/30826264 http://dx.doi.org/10.1016/j.chemphyslip.2019.02.009 |
_version_ | 1783409118488297472 |
---|---|
author | Falke, Marcel Victor, Julian Wördehoff, Michael M. Peduzzo, Alessia Zhang, Tao Schröder, Gunnar F. Buell, Alexander K. Hoyer, Wolfgang Etzkorn, Manuel |
author_facet | Falke, Marcel Victor, Julian Wördehoff, Michael M. Peduzzo, Alessia Zhang, Tao Schröder, Gunnar F. Buell, Alexander K. Hoyer, Wolfgang Etzkorn, Manuel |
author_sort | Falke, Marcel |
collection | PubMed |
description | Aggregation of the protein α-Synuclein (αSyn) is of great interest due to its involvement in the pathology of Parkinson’s disease. However, under in vitro conditions αSyn is very soluble and kinetically stable for extended time periods. As a result, most αSyn aggregation assays rely on conditions that artificially induce or enhance aggregation, often by introducing rather non-native conditions. It has been shown that αSyn interacts with membranes and conditions have been identified in which membranes can promote as well as inhibit αSyn aggregation. It has also been shown that αSyn has the intrinsic capability to assemble lipid-protein-particles, in a similar way as apolipoproteins can form lipid-bilayer nanodiscs. Here we show that these αSyn-lipid particles (αSyn-LiPs) can also effectively induce, accelerate or inhibit αSyn aggregation, depending on the applied conditions. αSyn-LiPs therefore provide a general platform and additional tool, complementary to other setups, to study various aspects of αSyn amyloid fibril formation. |
format | Online Article Text |
id | pubmed-6451039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier Science Ireland Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-64510392019-05-01 α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation Falke, Marcel Victor, Julian Wördehoff, Michael M. Peduzzo, Alessia Zhang, Tao Schröder, Gunnar F. Buell, Alexander K. Hoyer, Wolfgang Etzkorn, Manuel Chem Phys Lipids Article Aggregation of the protein α-Synuclein (αSyn) is of great interest due to its involvement in the pathology of Parkinson’s disease. However, under in vitro conditions αSyn is very soluble and kinetically stable for extended time periods. As a result, most αSyn aggregation assays rely on conditions that artificially induce or enhance aggregation, often by introducing rather non-native conditions. It has been shown that αSyn interacts with membranes and conditions have been identified in which membranes can promote as well as inhibit αSyn aggregation. It has also been shown that αSyn has the intrinsic capability to assemble lipid-protein-particles, in a similar way as apolipoproteins can form lipid-bilayer nanodiscs. Here we show that these αSyn-lipid particles (αSyn-LiPs) can also effectively induce, accelerate or inhibit αSyn aggregation, depending on the applied conditions. αSyn-LiPs therefore provide a general platform and additional tool, complementary to other setups, to study various aspects of αSyn amyloid fibril formation. Elsevier Science Ireland Ltd 2019-05 /pmc/articles/PMC6451039/ /pubmed/30826264 http://dx.doi.org/10.1016/j.chemphyslip.2019.02.009 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Falke, Marcel Victor, Julian Wördehoff, Michael M. Peduzzo, Alessia Zhang, Tao Schröder, Gunnar F. Buell, Alexander K. Hoyer, Wolfgang Etzkorn, Manuel α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation |
title | α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation |
title_full | α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation |
title_fullStr | α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation |
title_full_unstemmed | α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation |
title_short | α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation |
title_sort | α-synuclein-derived lipoparticles in the study of α-synuclein amyloid fibril formation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451039/ https://www.ncbi.nlm.nih.gov/pubmed/30826264 http://dx.doi.org/10.1016/j.chemphyslip.2019.02.009 |
work_keys_str_mv | AT falkemarcel asynucleinderivedlipoparticlesinthestudyofasynucleinamyloidfibrilformation AT victorjulian asynucleinderivedlipoparticlesinthestudyofasynucleinamyloidfibrilformation AT wordehoffmichaelm asynucleinderivedlipoparticlesinthestudyofasynucleinamyloidfibrilformation AT peduzzoalessia asynucleinderivedlipoparticlesinthestudyofasynucleinamyloidfibrilformation AT zhangtao asynucleinderivedlipoparticlesinthestudyofasynucleinamyloidfibrilformation AT schrodergunnarf asynucleinderivedlipoparticlesinthestudyofasynucleinamyloidfibrilformation AT buellalexanderk asynucleinderivedlipoparticlesinthestudyofasynucleinamyloidfibrilformation AT hoyerwolfgang asynucleinderivedlipoparticlesinthestudyofasynucleinamyloidfibrilformation AT etzkornmanuel asynucleinderivedlipoparticlesinthestudyofasynucleinamyloidfibrilformation |